Chronic hypertension medical therapy blood pressure goals of treatment

Revision as of 03:39, 10 May 2022 by Badgettrg (talk | contribs)
Jump to navigation Jump to search

Chronic Hypertension Microchapters

Home

2017 ACC/AHA Hypertension Guidelines

Patient Information

Overview

Definition

Classification

Pathophysiology

Causes

Differentiating Hypertension from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Blood Pressure Measurement

Physical Examination

Laboratory Findings

Electrocardiogram

ETT

Echocardiography

CT

MRI

Other Diagnostic Studies

Treatment

Lifestyle Modification

Medical Therapy

Practice Guidelines

Case Studies

Case #1

Chronic hypertension medical therapy blood pressure goals of treatment On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chronic hypertension medical therapy blood pressure goals of treatment

CDC on Chronic hypertension medical therapy blood pressure goals of treatment

Chronic hypertension medical therapy blood pressure goals of treatment in the news

Blogs on Chronic hypertension medical therapy blood pressure goals of treatment

Directions to Hospitals Treating Chronic hypertension medical therapy blood pressure goals of treatment

Risk calculators and risk factors for Chronic hypertension medical therapy blood pressure goals of treatment

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Deputy Editor-In-Chief Robert G. Badgett, M.D.[2]

The 24-hour ambulatory systolic pressure may better mortality than the daytime systolic blood pressure.

Regarding the accuracy of office oscillometric and home blood pressure monitoring compared with ambulatory blood pressure monitoring, a meta-analysis by the Rational Clinical Examination found:

  • Office pressures (presumably attended by medical personnel) has sensitivity and specificity of 51% and 88%
  • Home monitoring has sensitivity and specificity of 75% and 76%

Elevated high-sensitivity cardiac troponin T (hscTnT) and N-terminal pro-B-type natriuretic peptide (NTproBNP) levels may help guide treatment.

The decision to treat may be affected by projected longevity of a patient[1]:

  • "for patients 60 years and older with hypertension, intensive BP treatment may be appropriate for some adults with a life expectancy of greater than 3 years
  • "but may not be suitable for those with less than 1 year."

Clinical practice guidelines

Recommendations for treatment goals from recent clinical practice guidelines are tabulated below. However, treated based on underlying risk rather than a blood pressure target may be more effective. The logic supporting a target of 130/80 mm Hg has been disputed and the Cochrane Collaboration found insufficient evidence to determine a treatment goal for adults or adults over 65 years of age.

If the goal is 130/80, proper measurement includes (distilled from Table 8 of the ACC/AHA guidelines, executive summary):

  • having the patient sit quietly for 5 minutes before a reading is taken
  • supporting the limb used to measure BP
  • ensuring the BP cuff is at heart level
  • using the correct cuff size
  • for auscultatory readings, deflating the cuff slowly
  • the timing of BP measurements in relation to ingestion of the patient’s medication should be standardized
  • a single reading is inadequate for clinical decision-making. An average of 2 to 3 BP measurements obtained on 2 to 3 separate occasions will minimize random error and provide a more accurate basis for estimation of BP.

If the above measurement methods are not use, a preliminary study from Kaiser Northern California suggests a target of 140 mm Hg.

AHA vs Roerecke estimates of relationship between routine, auscultated BP measurement and gold standard ambulatory measurement.
Clinic (routine)

AHA, 2017

  1. Chen T, Shao F, Chen K, Wang Y, Wu Z, Wang Y; et al. (2022). "Time to Clinical Benefit of Intensive Blood Pressure Lowering in Patients 60 Years and Older With Hypertension: A Secondary Analysis of Randomized Clinical Trials". JAMA Intern Med. doi:10.1001/jamainternmed.2022.1657. PMID 35532917 Check |pmid= value (help).